Showing results (211-220 of 238) with videos related to

Sort By:
Pageof 24
Epilepsia|April 29, 2025
Distinct gray matter and metabolic characteristics in hypothalamic hamartoma network with different semiologyYihe Wang, Tao Feng, Fenglai Xiao, et al.
International Journal of Clinical Practice|October 9, 2021
Is there a role for natural desiccated thyroid in the treatment of levothyroxine unresponsive hypothyroidism? Results from a consecutive case seriesAdrian H Heald, Lakdasa Premawardhana, Peter Taylor, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial)Mohd Shazli Draman, Daniel S Morris, Sam Evans, et al.
The Journal of Antimicrobial Chemotherapy|March 23, 2018
Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigationSebastiaan J van Hal, Alicia G Beukers, Verlaine J Timms, et al.
Veterinary Clinical Pathology|June 19, 2002
Discriminant and multiple regression analysis of anemia and opportunistic infection in Fell pony foalsJohn B. Dixon, Malcolm Savage, Andrew Wattret, et al.
Epilepsia|July 11, 2024
Predictors of long-term memory and network connectivity 10 years after anterior temporal lobe resectionMarine N Fleury, Lawrence P Binding, Peter Taylor, et al.
Nature Communications|January 15, 2025
Long-term memory plasticity in a decade-long connectivity study post anterior temporal lobe resectionMarine N Fleury, Lawrence P Binding, Peter Taylor, et al.
Annals of the Rheumatic Diseases|June 9, 2016
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trialJose M Álvaro-Gracia, Juan A Jover, Rosario García-Vicuña, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2023
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED TrialPeter Taylor, Rathie Rajendram, Stephanie Hanna, et al.
Lancet (London, England)|May 21, 2016
Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trialDuncan Porter, Jurgen van Melckebeke, James Dale, et al.
Pageof 24